Stock comparison
Medline Inc. is 41.8x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.17 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 41.8x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.17 B).
Market value leader
MDLN
Medline Inc. is 41.8x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.17 B).
Revenue leader
MDLN
PRCT: $308.05M vs MDLN: $28.43B.
Profit leader
MDLN
PRCT: -$95.57K vs MDLN: $1.16T.
Margin leader
MDLN
PRCT: -0.0% vs MDLN: 4069.4% net margin.
| Metric | PRCT | MDLN |
|---|---|---|
| Market cap | $1.17 B | $49.12 B |
| US-listed rank | #2537 | #330 |
| Revenue (latest FY) | $308.05M | $28.43B |
| Net income (latest FY) | -$95.57K | $1.16T |
| Net margin | -0.0% | 4069.4% |
| P/E (trailing FY) | - | 0.0x |
| SEC filings | 360 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 41.8x more valuable than PROCEPT BioRobotics Corp by market capitalization ($49.12 B vs $1.17 B).
In their latest fiscal years, PROCEPT BioRobotics Corp reported $308.05M in revenue while Medline Inc. reported $28.43B.
Full pages: PROCEPT BioRobotics Corp and Medline Inc., or browse the full rankings.